Eric Gibbs

Lost Money in Amylyx Pharmaceuticals, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Friday, March 8, 2024

Gibbs Law Group reminds investors that a lawsuit has been filed against Amylyx Pharmaceuticals, Inc. (“Amylyx Pharmaceuticals”) (NASDAQ: AMLX), on behalf of investors who purchased or acquired shares between November 11, 2022, and November 8, 2023.

Key Points: 
  • Gibbs Law Group reminds investors that a lawsuit has been filed against Amylyx Pharmaceuticals, Inc. (“Amylyx Pharmaceuticals”) (NASDAQ: AMLX), on behalf of investors who purchased or acquired shares between November 11, 2022, and November 8, 2023.
  • What Should Amylyx Pharmaceuticals Investors Do?
  • Our investigation concerns whether Amylyx Pharmaceuticals has violated federal securities laws by providing false or misleading statements to investors.
  • Following this announcement, Amylyx Pharmaceuticals shares plummeted over 81% in intraday trading on March 8, 2024, causing significant harm to investors.

Lost Money in Infinera? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Friday, March 8, 2024

Shares of Infinera Corporation dropped over 11% on March 7, 2024, after the company found “material weaknesses” in its financial reporting—following an independent audit.

Key Points: 
  • Shares of Infinera Corporation dropped over 11% on March 7, 2024, after the company found “material weaknesses” in its financial reporting—following an independent audit.
  • Gibbs Law Group is investigating a potential Infinera Securities Class Action Lawsuit on behalf of shareholders who lost money in Infinera Corporation (NASDAQ: INFN).
  • Our investigation concerns whether Infinera Corporation has violated federal securities laws by providing false or misleading statements to investors.
  • What is the Infinera Securities Lawsuit Investigation About?

Lost Money in the Chemours Company? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Friday, March 1, 2024

Gibbs Law Group is investigating a potential Chemours Company Securities Class Action Lawsuit on behalf of shareholders who lost money in The Chemours Company (NYSE: CC).

Key Points: 
  • Gibbs Law Group is investigating a potential Chemours Company Securities Class Action Lawsuit on behalf of shareholders who lost money in The Chemours Company (NYSE: CC).
  • Our investigation concerns whether Chemours has violated federal securities laws by providing false or misleading statements to investors.
  • What is the Chemours Company Securities Lawsuit Investigation About?
  • Following Chemours’ announcement, the stock plummeted over 31% on February 29th, causing significant harm to investors.

Lost Money in Fluence Energy, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Friday, February 23, 2024

Gibbs Law Group is investigating a potential Fluence Securities Class Action Lawsuit on behalf of shareholders who lost money in Fluence Energy, Inc. (NASDAQ: FLNC).

Key Points: 
  • Gibbs Law Group is investigating a potential Fluence Securities Class Action Lawsuit on behalf of shareholders who lost money in Fluence Energy, Inc. (NASDAQ: FLNC).
  • If you invested in Fluence, visit our website by clicking here , or call us toll-free at (888) 410-2925 to discuss how you may be able to recover your losses.
  • Our investigation concerns whether Fluence has violated federal securities laws by providing false or misleading statements to investors.
  • What is the Fluence Securities Lawsuit Investigation About?

Lost Money in Trupanion, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Saturday, February 17, 2024

Shares of Trupanion, Inc. (“Trupanion”) dropped over 35% on February 16, 2024, after the company revealed that it “expects to report two material weaknesses in internal controls.” Gibbs Law Group is investigating a potential Trupanion, Inc. Securities Class Action Lawsuit on behalf of shareholders who lost money in Trupanion, Inc. (NASDAQ: TRUP).

Key Points: 
  • Shares of Trupanion, Inc. (“Trupanion”) dropped over 35% on February 16, 2024, after the company revealed that it “expects to report two material weaknesses in internal controls.” Gibbs Law Group is investigating a potential Trupanion, Inc. Securities Class Action Lawsuit on behalf of shareholders who lost money in Trupanion, Inc. (NASDAQ: TRUP).
  • Our investigation concerns whether Trupanion, Inc. has violated federal securities laws by providing false or misleading statements to investors.
  • On February 15, 2024, Trupanion released preliminary financial results for the fourth quarter and full year ended December 31, 2023 and identified two material weaknesses.
  • Following this news, the stock plunged over 35% trading on February 16th, 2024, causing serious harm to investors.

Lost Money in The Chemours Company? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Thursday, February 15, 2024

Gibbs Law Group is investigating a potential Chemours Company Securities Class Action Lawsuit on behalf of shareholders who lost money in The Chemours Company (NYSE: CC).

Key Points: 
  • Gibbs Law Group is investigating a potential Chemours Company Securities Class Action Lawsuit on behalf of shareholders who lost money in The Chemours Company (NYSE: CC).
  • Our investigation concerns whether Chemours Company has violated federal securities laws by providing false or misleading statements to investors.
  • What is The Chemours Company Securities Lawsuit Investigation About?
  • Following Chemours’ announcement, the stock dropped over 12% in intraday trading on February 14th, causing harm to investors.

Lost Money in Amylyx Pharmaceuticals, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Wednesday, February 14, 2024

Gibbs Law Group announces that a lawsuit has been filed against Amylyx Pharmaceuticals, Inc. (“Amylyx Pharmaceuticals”) (NASDAQ: AMLX), on behalf of investors who purchased or acquired shares between November 11, 2022, and November 8, 2023.

Key Points: 
  • Gibbs Law Group announces that a lawsuit has been filed against Amylyx Pharmaceuticals, Inc. (“Amylyx Pharmaceuticals”) (NASDAQ: AMLX), on behalf of investors who purchased or acquired shares between November 11, 2022, and November 8, 2023.
  • Our investigation concerns whether Amylyx Pharmaceuticals has violated federal securities laws by providing false or misleading statements to investors.
  • On November 9, 2023, biotechnology company Amylyx Pharmaceuticals announced its 2023 Q3 financial results and hosted a conference call to discuss these results.
  • Following this news, Amylyx Pharmaceuticals shares plummeted over 31% on November 9, 2023, causing significant harm to investors.

Lost Money in Soho House & Co Inc.? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Wednesday, February 7, 2024

Gibbs Law Group is investigating a potential Soho House Securities Class Action Lawsuit on behalf of shareholders who lost money in Soho House (NYSE: SHCO).

Key Points: 
  • Gibbs Law Group is investigating a potential Soho House Securities Class Action Lawsuit on behalf of shareholders who lost money in Soho House (NYSE: SHCO).
  • If you invested in Soho House & Co Inc., visit our website by clicking here, or call us toll-free at (888) 410-2925 to discuss how you may be able to recover your losses.
  • Our investigation concerns whether Soho House has violated federal securities laws by providing false or misleading statements to investors.
  • What is the Soho House Securities Lawsuit Investigation About?

Lost Money in Dada Nexus? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Tuesday, February 6, 2024

Gibbs Law Group encourages Dada Nexus Limited (“Dada”) (NASDAQ: DADA) investors to contact us to discuss their legal rights and options.

Key Points: 
  • Gibbs Law Group encourages Dada Nexus Limited (“Dada”) (NASDAQ: DADA) investors to contact us to discuss their legal rights and options.
  • A lawsuit has been filed on behalf of Dada investors who purchased or acquired shares between May 11, 2023 and January 8, 2024.
  • If you purchased Dada securities during the Class Period, you may be entitled to potential compensation without paying any out-of-pocket fees or costs.
  • Following this news, Dada stock plummeted over 45% in intraday trading on January 8, 2024, causing significant harm to investors.

Lost Money in Adtalem Global Education? Gibbs Law Group Investigates Potential Securities Law Violations

Retrieved on: 
Wednesday, January 31, 2024

Gibbs Law Group is investigating a potential Adtalem Securities Class Action Lawsuit on behalf of shareholders who lost money in Adtalem (NYSE: ATGE).

Key Points: 
  • Gibbs Law Group is investigating a potential Adtalem Securities Class Action Lawsuit on behalf of shareholders who lost money in Adtalem (NYSE: ATGE).
  • If you purchased Adtalem securities during the Class Period, you may be entitled to potential compensation without paying any out-of-pocket fees or costs.
  • In November, Walden University which was acquired by Adtalem, was put under investigation by the Department of Education.
  • Following the short seller report, Adtalem stock plummeted over 23% in intraday trading on January 30th, causing significant harm to investors.